Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer

Detect plasma Hsp90α concentration of colorectal cancer patients, healthy volunteers, benign colorectal diseases patients.

Study Overview

• Status: Unknown
• Conditions: Colorectal Cancer
• Intervention / Treatment: Device: Hsp90

Detailed Description

Detect plasma Hsp90α concentration of colorectal cancer patients, healthy volunteers, benign colorectal diseases patients, validate accuracy, specificity and sensitivity of Hsp90α kit.

• Study Type: Interventional
• Enrollment (Anticipated): 1100
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Xianrang Song, MD; Phone Number: 87984777 0531
• Study Contact Backup: Name: Lisheng Liu, MD; Phone Number: 87984777 0531; Email: wufei@protgen.com

Study Locations

• China
  • Shandong
    • Jinan, Shandong, China
      • Recruiting
      • Shandong province cancer hospital
      • Contact: Lisheng Liu, MD; Phone Number: 87984777 0531; Email: wufei@protgen.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• colorectal cancer patients, healthy volunteers, benign colorectal diseases patients

Exclusion Criteria:

• Patients who previously accepted radiotherapy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Rectal cancer; Detect plasma Hsp90α concentration of patients,	Device: Hsp90; Detect plasma Hsp90α concentration; Other Names: biomarker

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Hsp90α Concentration(ng/ml) of plasma	Detect Hsp90α Concentration(ng/ml) of plasma and calculate the accuracy, specificity and sensitivity of Hsp90α kit	4 months

Collaborators and Investigators

• Sponsor: Protgen Ltd
• Investigators: Principal Investigator: Jinming Yu, MD, Shandong province cancer hospital

Study record dates

Study Major Dates

• Study Start: September 1, 2012
• Primary Completion (Anticipated): December 1, 2014
• Study Completion (Anticipated): December 1, 2014

Study Registration Dates

• First Submitted: December 14, 2014
• First Submitted That Met QC Criteria: December 22, 2014
• First Posted (Estimate): December 24, 2014

Study Record Updates

• Last Update Posted (Estimate): December 24, 2014
• Last Update Submitted That Met QC Criteria: December 22, 2014
• Last Verified: December 1, 2014

More Information

Terms related to this study

• Keywords: Cancer
• Additional Relevant MeSH Terms: Digestive System Diseases; Neoplasms; Neoplasms by Site; Gastrointestinal Neoplasms; Digestive System Neoplasms; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Colorectal Neoplasms
• Other Study ID Numbers: hsp90a2011-03